help button home button Endocrine Society JCEM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Full Text (PDF)
Right arrow Submit a related Letter to the Editor
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Karl, M.
Right arrow Articles by Chrousos, G. P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Karl, M.
Right arrow Articles by Chrousos, G. P.

Journal of Clinical Endocrinology & Metabolism, Vol 76, 683-689, Copyright © 1993 by Endocrine Society


ARTICLES

Familial glucocorticoid resistance caused by a splice site deletion in the human glucocorticoid receptor gene

M Karl, SW Lamberts, SD Detera-Wadleigh, IJ Encio, CA Stratakis, DM Hurley, D Accili and GP Chrousos
Developmental Endocrinology Branch, National Institute of Child Health and Human Development, National Institutes of Health, Bethesda, Maryland 20892.

The clinical syndrome of generalized, compensated glucocorticoid resistance is characterized by increased cortisol secretion without clinical evidence of hyper- or hypocortisolism, and manifestations of androgen and/or mineralocorticoid excess. This condition results from partial failure of the glucocorticoid receptor (GR) to modulate transcription of its target genes. We studied the molecular mechanisms of this syndrome in a Dutch kindred, whose affected members had hypercortisolism and approximately half of normal GRs, and whose proband was a young woman with manifestations of hyperandrogenism. Using the polymerase chain reaction to amplify and sequence each of the nine exons of the GR gene alpha, along with their 5'- and 3'-flanking regions, we identified a 4-base deletion at the 3'-boundary of exon 6 in one GR allele (delta 4), which removed a donor splice site in all three affected members studied. In contrast, the sequence of exon 6 in the two unaffected siblings was normal. A single nucleotide substitution causing an amino acid substitution in the amino terminal domain of the GR (asparagine to serine, codon 363) was also discovered in exon 2 of the other allele (G1220) in the proband, in one of her affected brothers and in her unaffected sister. The functional importance of this mutation was tested in a cotransfection study using the recombinant expression vector pRShGR-Ser363 and the glucocorticoid responsive vector mouse mammary tumor virus-chloramphenicol transferase. This amino acid substitution did not alter the function of the glucocorticoid receptor. Using reverse transcription-polymerase chain reaction we could only identify messenger RNA transcripts of the G1220-allele but not of the delta 4-allele in the affected members of this family who were heterozygous for the G1220 mutation. This deletion in the glucocorticoid receptor gene was, thus, associated with the expression of only one allele and a decrease of GR protein by 50% in affected members of this glucocorticoid resistant family. The mutation identified in exon 2 did not segregate with the disease and appears to be of no functional significance. The presence of the null allele was apparently compensated for by increased cortisol production at the expense of concurrent hyperandrogenism.


This article has been cited by other articles:


Home page
J. Med. Genet.Home page
M Neves-Pereira, B Muller, D Massie, J H G Williams, P C M O'Brien, A Hughes, S-B Shen, D. S. Clair, and Z Miedzybrodzka
Deregulation of EIF4E: a novel mechanism for autism
J. Med. Genet., November 1, 2009; 46(11): 759 - 765.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
J. Zhang, R. Ge, C. Matte-Martone, J. Goodwin, W. D. Shlomchik, M. J. Mamula, A. Kooshkabadi, M. P. Hardy, and D. Geller
Characterization of a Novel Gain of Function Glucocorticoid Receptor Knock-in Mouse
J. Biol. Chem., March 6, 2009; 284(10): 6249 - 6259.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
E. Charmandari, T. Kino, T. Ichijo, and G. P. Chrousos
Generalized Glucocorticoid Resistance: Clinical Aspects, Molecular Mechanisms, and Implications of a Rare Genetic Disorder
J. Clin. Endocrinol. Metab., May 1, 2008; 93(5): 1563 - 1572.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
E. Charmandari, T. Kino, T. Ichijo, W. Jubiz, L. Mejia, K. Zachman, and G. P. Chrousos
A Novel Point Mutation in Helix 11 of the Ligand-Binding Domain of the Human Glucocorticoid Receptor Gene Causing Generalized Glucocorticoid Resistance
J. Clin. Endocrinol. Metab., October 1, 2007; 92(10): 3986 - 3990.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
C. M. Jewell and J. A. Cidlowski
Molecular Evidence for a Link between the N363S Glucocorticoid Receptor Polymorphism and Altered Gene Expression
J. Clin. Endocrinol. Metab., August 1, 2007; 92(8): 3268 - 3277.
[Abstract] [Full Text] [PDF]


Home page
J. Neurol. Neurosurg. PsychiatryHome page
D M Bonifati, S F Witchel, M Ermani, E P Hoffman, C Angelini, and E Pegoraro
The glucocorticoid receptor N363S polymorphism and steroid response in Duchenne dystrophy
J. Neurol. Neurosurg. Psychiatry, October 1, 2006; 77(10): 1177 - 1179.
[Abstract] [Full Text] [PDF]


Home page
J. Am. Soc. Nephrol.Home page
D. S. Geller, J. Zhang, M.-C. Zennaro, A. Vallo-Boado, J. Rodriguez-Soriano, L. Furu, R. Haws, D. Metzger, B. Botelho, L. Karaviti, et al.
Autosomal Dominant Pseudohypoaldosteronism Type 1: Mechanisms, Evidence for Neonatal Lethality, and Phenotypic Expression in Adults
J. Am. Soc. Nephrol., May 1, 2006; 17(5): 1429 - 1436.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
E. Charmandari, T. Kino, T. Ichijo, K. Zachman, A. Alatsatianos, and G. P. Chrousos
Functional Characterization of the Natural Human Glucocorticoid Receptor (hGR) Mutants hGR{alpha}R477H and hGR{alpha}G679S Associated with Generalized Glucocorticoid Resistance
J. Clin. Endocrinol. Metab., April 1, 2006; 91(4): 1535 - 1543.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
H. Russcher, P. Smit, E. F. C. van Rossum, E. L. T. van den Akker, A. O. Brinkmann, L. J. M. de Heide, F. H. de Jong, J. W. Koper, and S. W. J. Lamberts
Strategies for the Characterization of Disorders in Cortisol Sensitivity
J. Clin. Endocrinol. Metab., February 1, 2006; 91(2): 694 - 701.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
J. A.E. Irving, L. Minto, S. Bailey, and A. G. Hall
Loss of Heterozygosity and Somatic Mutations of the Glucocorticoid Receptor Gene Are Rarely Found at Relapse in Pediatric Acute Lymphoblastic Leukemia but May Occur in a Subpopulation Early in the Disease Course
Cancer Res., November 1, 2005; 65(21): 9712 - 9718.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
R. S. Chriguer, L. L. K. Elias, I. M. da Silva Jr., J. G. H. Vieira, A. C. Moreira, and M. de Castro
Glucocorticoid Sensitivity in Young Healthy Individuals: in Vitro and in Vivo Studies
J. Clin. Endocrinol. Metab., November 1, 2005; 90(11): 5978 - 5984.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
W. J.E. Tissing, J. P.P. Meijerink, M. L. den Boer, B. Brinkhof, E. F.C. van Rossum, E. R. van Wering, J. W. Koper, P. Sonneveld, and R. Pieters
Genetic Variations in the Glucocorticoid Receptor Gene Are Not Related to Glucocorticoid Resistance in Childhood Acute Lymphoblastic Leukemia
Clin. Cancer Res., August 15, 2005; 11(16): 6050 - 6056.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
E. Charmandari, A. Raji, T. Kino, T. Ichijo, A. Tiulpakov, K. Zachman, and G. P. Chrousos
A Novel Point Mutation in the Ligand-Binding Domain (LBD) of the Human Glucocorticoid Receptor (hGR) Causing Generalized Glucocorticoid Resistance: The Importance of the C Terminus of hGR LBD in Conferring Transactivational Activity
J. Clin. Endocrinol. Metab., June 1, 2005; 90(6): 3696 - 3705.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
E. Charmandari, T. Kino, E. Souvatzoglou, A. Vottero, N. Bhattacharyya, and G. P. Chrousos
Natural Glucocorticoid Receptor Mutants Causing Generalized Glucocorticoid Resistance: Molecular Genotype, Genetic Transmission, and Clinical Phenotype
J. Clin. Endocrinol. Metab., April 1, 2004; 89(4): 1939 - 1949.
[Abstract] [Full Text] [PDF]


Home page
Recent Prog Horm ResHome page
E. F.C. van Rossum and S. W.J. Lamberts
Polymorphisms in the Glucocorticoid Receptor Gene and Their Associations with Metabolic Parameters and Body Composition
Recent Prog. Horm. Res., January 1, 2004; 59(1): 333 - 357.
[Abstract] [Full Text]


Home page
HypertensionHome page
R. Rosmond, B. J. Morris, R. C.Y. Lin, and X. L. Wang
Glucocorticoid Receptor Gene and Coronary Artery Disease: Right Idea, Wrong Gene Variant? * Response
Hypertension, August 1, 2003; e4(2): .
[Full Text] [PDF]


Home page
HypertensionHome page
R. C.Y. Lin, X. L. Wang, and B. J. Morris
Association of Coronary Artery Disease With Glucocorticoid Receptor N363S Variant
Hypertension, March 1, 2003; 41(3): 404 - 407.
[Abstract] [Full Text] [PDF]


Home page
DiabetesHome page
E. F.C. van Rossum, J. W. Koper, N. A.T.M. Huizenga, A. G. Uitterlinden, J. A.M.J.L. Janssen, A. O. Brinkmann, D. E. Grobbee, F. H. de Jong, C. M. van Duyn, H. A.P. Pols, et al.
A Polymorphism in the Glucocorticoid Receptor Gene, Which Decreases Sensitivity to Glucocorticoids In Vivo, Is Associated With Low Insulin and Cholesterol Levels
Diabetes, October 1, 2002; 51(10): 3128 - 3134.
[Abstract] [Full Text] [PDF]


Home page
Mol. Endocrinol.Home page
M. R. Yudt and J. A. Cidlowski
The Glucocorticoid Receptor: Coding a Diversity of Proteins and Responses through a Single Gene
Mol. Endocrinol., August 1, 2002; 16(8): 1719 - 1726.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
A. Vottero, T. Kino, H. Combe, P. Lecomte, and G. P. Chrousos
A Novel, C-Terminal Dominant Negative Mutation of the GR Causes Familial Glucocorticoid Resistance through Abnormal Interactions with p160 Steroid Receptor Coactivators
J. Clin. Endocrinol. Metab., June 1, 2002; 87(6): 2658 - 2667.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
B. B. Mendonca, M. V. Leite, M. de Castro, T. Kino, L. L. K. Elias, T. A. S. Bachega, I. J. P. Arnhold, G. P. Chrousos, and A. C. Latronico
Female Pseudohermaphroditism Caused by a Novel Homozygous Missense Mutation of the GR Gene
J. Clin. Endocrinol. Metab., April 1, 2002; 87(4): 1805 - 1809.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
T. Kino, R. H. Stauber, J. H. Resau, G. N. Pavlakis, and G. P. Chrousos
Pathologic Human GR Mutant Has a Transdominant Negative Effect on the Wild-Type GR by Inhibiting Its Translocation into the Nucleus: Importance of the Ligand-Binding Domain for Intracellular GR Trafficking
J. Clin. Endocrinol. Metab., November 1, 2001; 86(11): 5600 - 5608.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
P. de Lange, C. M. Segeren, J. W. Koper, E. Wiemer, P. Sonneveld, A. O. Brinkmann, A. White, I. J. Brogan, F. H. de Jong, and S. W. J. Lamberts
Expression in Hematological Malignancies of a Glucocorticoid Receptor Splice Variant That Augments Glucocorticoid Receptor-mediated Effects in Transfected Cells
Cancer Res., May 1, 2001; 61(10): 3937 - 3941.
[Abstract] [Full Text]


Home page
J. Clin. Endocrinol. Metab.Home page
N. A. T. M. Huizenga, P. de Lange, J. W. Koper, W. W. de Herder, R. Abs, J. H. L. M. v. Kasteren, F. H. de Jong, and S. W. J. Lamberts
Five Patients with Biochemical and/or Clinical Generalized Glucocorticoid Resistance without Alterations in the Glucocorticoid Receptor Gene
J. Clin. Endocrinol. Metab., May 1, 2000; 85(5): 2076 - 2081.
[Abstract] [Full Text]


Home page
Cancer Res.Home page
A. G. Hillmann, J. Ramdas, K. Multanen, M. R. Norman, and J. M. Harmon
Glucocorticoid Receptor Gene Mutations in Leukemic Cells Acquired in Vitro and in Vivo
Cancer Res., April 1, 2000; 60(7): 2056 - 2062.
[Abstract] [Full Text]


Home page
J. Clin. Endocrinol. Metab.Home page
Adrenal Hyperandrogenism in Children
J. Clin. Endocrinol. Metab., December 1, 1999; 84(12): 4431 - 4435.
[Full Text]


Home page
HypertensionHome page
R. C. Y. Lin, W. Y. S. Wang, and B. J. Morris
Association and Linkage Analyses of Glucocorticoid Receptor Gene Markers in Essential Hypertension
Hypertension, December 1, 1999; 34(6): 1186 - 1192.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
M.-C. Keightley, A. J. Curtis, S. Chu, and P. J. Fuller
Structural Determinants of Cortisol Resistance in the Guinea Pig Glucocorticoid Receptor
Endocrinology, May 1, 1998; 139(5): 2479 - 2485.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
N. A. T. M. Huizenga, P. de Lange, J. W. Koper, R. N. Clayton, W. E. Farrell, A. J. van der Lely, A. O. Brinkmann, F. H. de Jong, and S. W. J. Lamberts
Human Adrenocorticotropin-Secreting Pituitary Adenomas Show Frequent Loss of Heterozygosity at the Glucocorticoid Receptor Gene Locus
J. Clin. Endocrinol. Metab., March 1, 1998; 83(3): 917 - 921.
[Abstract] [Full Text]


Home page
J. Clin. Endocrinol. Metab.Home page
N. A. T. M. Huizenga, J. W. Koper, P. de Lange, H. A. P. Pols, R. P. Stolk, H. Burger, D. E. Grobbee, A. O. Brinkmann, F. H. de Jong, and S. W. J. Lamberts
A Polymorphism in the Glucocorticoid Receptor Gene May Be Associated with an Increased Sensitivity to Glucocorticoids in Vivo
J. Clin. Endocrinol. Metab., January 1, 1998; 83(1): 144 - 151.
[Abstract] [Full Text]


Home page
EndocrinologyHome page
S. Karanth, A. C. E. Linthorst, G. K. Stalla, N. Barden, F. Holsboer, and J. M. H. M. Reul
Hypothalamic-Pituitary-Adrenocortical Axis Changes in a Transgenic Mouse with Impaired Glucocorticoid Receptor Function
Endocrinology, August 1, 1997; 138(8): 3476 - 3485.
[Abstract] [Full Text] [PDF]


Home page
Mol. Endocrinol.Home page
P. de Lange, J. W. Koper, N. A. T. M. Huizenga, A. O. Brinkmann, F. H. de Jong, M. Karl, G. P. Chrousos, and S. W. J. Lamberts
Differential Hormone-Dependent Transcriptional Activation and -Repression by Naturally Occurring Human Glucocorticoid Receptor Variants
Mol. Endocrinol., July 1, 1997; 11(8): 1156 - 1164.
[Abstract] [Full Text]


Home page
EndocrinologyHome page
N. B. E. Oldenburg, R. B. Evans-Storms, and J. A. Cidlowski
In Vivo Resistance to Glucocorticoid-Induced Apoptosis in Rat Thymocytes with Normal Steroid Receptor Function in Vitro
Endocrinology, February 1, 1997; 138(2): 810 - 818.
[Abstract] [Full Text] [PDF]


Home page
ScienceHome page
L Richeldi, R Sorrentino, and C Saltini
HLA-DPB1 glutamate 69: a genetic marker of beryllium disease
Science, October 8, 1993; 262(5131): 242 - 244.
[Abstract] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 1993 by The Endocrine Society